Skip to main content

Table 1 Clinical characteristics of diabetic and non-diabetic patients with KPLA

From: The emergence of Klebsiella pneumoniae liver abscess in non-diabetic patients and the distribution of capsular types

  Non-DM
(n = 120)
DM
(n = 110)
p
Age in years 64.1 ± 16.3 63.5 ± 14.6 0.779
Male 69 (57.5) 80 (72.7) 0.016
Charlson score 1.1 ± 1.8 2.4 ± 1.9 <0.001
Underlying disease
 Malignancy 11 (9.2) 10 (9.1) 0.984
 Alcoholism 4 (3.3) 8 (7.3) 0.180
 Chronic kidney disease 4 (3.3) 8 (7.3) 0.180
 Liver cirrhosis 5 (4.2) 1 (0.9) 0.215
 Congestive heart failure 8 (6.7) 5 (4.5) 0.487
 Chronic lung disease 5 (4.2) 5 (4.5) 1.000
 Cerebrovascular accident 11 (9.2) 8 (7.3) 0.602
APACHE II score 12.3 ± 6.9 14.5 ± 7.4 0.018
HbA1c 5.6 ± 1.2 9.2 ± 2.6 <0.001
Capsular type K1 and K2 94 (81.7)a 70 (70.7)b 0.057
Wild-type antibiotic susceptibility 113 (94.2) 103 (93.6) 0.867
Origin 0.749
 Cryptogenic 103 (85.8) 96 (87.3)
 Biliary tract origin 17 (14.2) 14 (12.7)
Abscess location 0.408
 Right lobe 77 (64.2) 79 (71.8)  
 Left lobe 21 (17.5) 17 (15.5)
 Both lobes 22 (18.3) 14 (12.7)
Abscess size 0.419
 <5 cm 51 (42.5) 41 (37.3)
 ≥5 cm 69 (57.5) 69 (62.7)
Gas-forming abscess 2 (1.7) 18 (16.4) <0.001
Multiple abscesses 18 (15.0) 15 (13.6) 0.768
Metastatic infection 6 (5.0) 12 (10.9) 0.096
Outcomes
 ICU admission 23 (19.2) 28 (25.5) 0.252
 Hospital days 26.9 ± 16.5 32.3 ± 38.5 0.178
 Mortality 4 (3.4) 4 (3.6) 0.910
  1. Data are presented as mean ± SD or frequency with percentage (%)
  2. a115 isolates were available for genotyping
  3. b99 isolates were available for genotyping